Anesthesia PraCtice for Cesarean DElivery Snapshot Survey: ACCESS Study

Dear Colleagues,
From the ESAIC-Obstetric Anaesthesiology Subcommittee 4, we are planning to launch a new survey study to assess anesthesia practice during cesarean delivery.

If you would be interested in your center participating, please complete this preliminary poll.
Each participating country will have several centers with a National Coordinator. 
Each participating center will have a Lead Investigator. 
You may have already been approached and agreed to participate. 

This poll is designed to evaluate/confirm your interest to be Lead Investigator of your study center, to estimate the total number of cesarean delivery cases that may be surveyed in total, and to collect your contact details in order to send further information. 

Our study goal is to recruit all consecutive cesarean deliveries in a 2 week (15-days) snapshot period in each participating center. This way we can gather information (limited number of outcomes) concerning anesthesia management of cesarean delivery.  

During the survey period, every anesthesiologist will complete the short survey after every cesarean delivery during the 2 week survey period. There will be no interventions with patients and data will be collected retrospectively, after completion of the cesarean delivery, thus it is expected that informed consent will not be required. However local institutional or national approval or waiver will be required. 

National Coordinators and Lead Investigators are entitled to study group publication authorship,  commensurate with contribution, as outlined in the study protocol you will receive after completion of the survey. 

The snapshot study is planned to open on September 1st 2023. This should give time for all centers to get the necessary approvals. Centers may specify their start date, once they have all the necessary approvals in place. 
Note that the data introduced in this survey will used for identifying potential ACCESS study centers and will follow the GDPR.

Thank you for your participation in the ACCESS study center identification poll. 

Survey: Anxiolytic premedication in Europe

Dear colleagues!

This is an European survey concerning anxiolytic and sedative premedication and is part of a PhD thesis on the impact of midazolam on pain. Main objectives are to clarify:

1. The actual standard of care concerning patient anxiety evaluation and management
2. The role of midazolam in modern practice.
3. The common perception of the impact of midazolam on patient outcomes.

If you work regularly in the operating theatre (anaesthetise at least 3 patients per month), we invite you to complete a short anonymous survey about your current practice concerning anxiolytic premedication. Predicted survey time is less than 15 minutes.  Ethical committee approval has been obtained and the survey complies to GDPR. The participation is voluntary and might be interrupted during the course of the test.

For any doubts or questions related to the survey, please contact via e-mail: caroline.dahlem@gmail.com

Please submit the survey only once. If you have previously responded to this survey in Portuguese, please do not submit it again.

We thank you in advance for your cooperation.
Caroline Dahlem, Carmen Oliveira , Cristina Granja, Luís Azevedo

Survey: Variation in ASA Scoring (Milestone-2)

Dear colleagues, 

The society is supporting the MILESTONE-2 survey, an international collaboration of (HPB) surgeons and anesthesiologist in which we want to explore the reasons behind the large variations seen in the ASA classification in patients undergoing HPB surgery. To what extent is this actually related to patient factors? 

A previous study of our group found large differences in ASA scores in HPB surgery between different countries (USA vs European). For pancreatic surgery: ASA III/IV in NSQIP 78%, in Germany 48%, in the Netherlands 23%, and in Sweden only 3%. Since ASA is also utilized for case mix adjustment it is vital that consensus is reached on the practicalities of this system.  

This online survey will only take 5-10 minutes to complete.

Best wishes,  
On behalf of the MILESTONE-2 team

EU survey initiated by Biomed Alliance regarding the availability of medical devices

Dear NASC members,

Biomed Alliance, who represents all leading medical societies in EU and of  which ESAIC is a member,  would appreciate your input to an important survey on the availability of medical devices. The survey was developed by BioMed Alliance in cooperation with ESC, and will help to address an important issue that can affect healthcare in Europe.

Reports from clinicians, the European Commission and manufacturers have shown that there are issues around the availability of medical devices. This problem may become worse in the coming period if measures are not taken to address it, as the deadline for recertification under MDR for a large group of devices is coming up. Many devices are at risk of being taken of the market with serious consequences for the provision of healthcare in Europe. For more information, see a recent BioMed Alliance press release on this topic.

This survey intends to assess whether clinicians in different fields are already experiencing issues around the availability of certain medical devices, which devices are affected and whether they expect to experience any issues in the future. The results will help Biomed Alliance  to gather more information on the extent of the issue and will serve as a basis for discussions with policy makers and stakeholders on this topic.

The survey is available here until 18 September.

Many thanks for your collaboration.

Best regards

On behalf of Federico Bilotta, NASC Chair